NCI-H292 cell line, a pulmonary MEC cell line with wild-type EGFR, demonstrates enhanced sensitivity to gefitinib compared with other NSCLC lines with wild-type EGFR[16]. Here, EGFR is linked to non-small cell lung carcinoma.